We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Are Antibody Tests Alone Enough to Detect HIV?

By LabMedica International staff writers
Posted on 30 Jun 2009
Antibody tests alone were insufficient to detect human immunodeficiency virus (HIV) in individuals.

Diagnosis of acute HIV infection relies on detection of HIV virus using viral load tests, or p24 antigen. More...
Pooled HIV viral load testing has been shown to be an effective means of diagnosing acute infections. However, it is slow, typically taking between 7 and 21 days to obtain the results, cumbersome, and laborious. It is, therefore, not a realistic technology for resource-limited settings, or for addressing the problem of ongoing transmission from people during acute infection.

The use of a test that combines rapid testing for HIV antibodies with an ultrasensitive p24 assay is an alternative. This should detect HIV infection several weeks earlier than previous generations of antibody tests in people recently infected. These fourth generation assays are now routinely used in some countries such as the United Kingdom.

Professor Susan H. Eshelman from the department of pathology, Johns Hopkins Medical Institutions (Baltimore, MD, USA), and colleagues used the Abbott (Abbott park, IL, USA) Architect HIV antigen/antibody (Ag/Ab) combo assay, to detect individuals with acute HIV-1 infection.

Testing for the antigen reduces the window period in which an individual might have been exposed to HIV and has a reactive test result. Thus, individuals exposed to HIV could test reactive for the antigen, but might not test reactive to the antibody. In this study, the Abbott combination assay detected 61.9 % of the acute infections whereas only 14.3 % of the acute samples were identified as positive by a third-generation antibody test. There were 21 acute infections among 217 samples from seronegative individuals.

The study was published online in the Journal of Acquired Immune Deficiency Syndromes (JAIDS), June 2009.

Related Links:
Johns Hopkins Medical Institutions
Abbott



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Hematology Analyzer
Medonic M32B
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.